NCT05548738

Brief Summary

This study will be held on patients with failed back surgery syndrome, the investigators are comparing prolotherapy and steroids injections in caudal epidural space to relieve the pain

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

1.6 years

First QC Date

September 14, 2022

Last Update Submit

November 26, 2024

Conditions

Keywords

caudal epiduralprolotherapysteroidsfailed back surgery

Outcome Measures

Primary Outcomes (1)

  • Assessing in both groups the Visual analogue scale from 0-10 where 0 indicates no pain and 10 indicates maximum pain

    A decrease in VAS score after 2 weeks by 50 percent or more from pre-injection level is considered successful

    2 weeks

Secondary Outcomes (4)

  • the level reached by the injectate

    at time of injection

  • assessing the patient satisfaction by a the short assessment of patient satisfaction score (SAPS) from 0 to 28 where 0 is so dissatisfied and 28 means very satisfied

    6 months

  • further change in visual analogue scale

    2 weeks till 6 months

  • recording the number of patients who encountered any complications and treating them accordingly

    6 months

Study Arms (2)

Steroid group (Group S)

ACTIVE COMPARATOR

This group will receive ultrasound and fluoroscopy-guided caudal epidural steroid injection

Drug: medthylprednisolone

Prolotherapy group (Group P)

EXPERIMENTAL

This group will receive ultrasound and fluoroscopy-guided caudal epidural prolotherapy injection

Drug: prolotherapy

Interventions

a type of steroids injected in epidural space

Also known as: steroids
Steroid group (Group S)

a type of hypertonic glucose

Also known as: dextrose 10%
Prolotherapy group (Group P)

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients diagnosed with failed back surgery syndrome, having chronic pain for more than 3 months by a detailed assessment including medical history and examination
  • patients having positive radiological (MRI) findings of spinal nerve roots being irritated or compressed after having surgery for one of many conditions including: lumbar disc herniation, spinal canal stenosis, osteophytes, spodylolithesis or foramen stenosis
  • patients whom another surgery is not indicated

You may not qualify if:

  • patient refusal
  • pregnancy
  • systemic infection or infection at the site of injection
  • patients on anticoagulation
  • immunocompromised patients as uncontrolled diabetes, osteoporosis as a contraindication for steroid injection
  • patients with renal impairment or on dialysis
  • acute disc prolapse as it requires immediate surgery
  • opioid use
  • concurrent significant depressive illness, inflammatory of joint disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed S. Shehab

Alexandria, Egypt

Location

Related Publications (1)

  • Maniquis-Smigel L, Reeves KD, Rosen HJ, Lyftogt J, Graham-Coleman C, Cheng AL, Rabago D. Analgesic Effect and Potential Cumulative Benefit from Caudal Epidural D5W in Consecutive Participants with Chronic Low-Back and Buttock/Leg Pain. J Altern Complement Med. 2018 Dec;24(12):1189-1196. doi: 10.1089/acm.2018.0085. Epub 2018 Jun 8.

MeSH Terms

Interventions

SteroidsProlotherapy

Intervention Hierarchy (Ancestors)

Fused-Ring CompoundsPolycyclic CompoundsComplementary TherapiesTherapeutics

Study Officials

  • Ahmed S shehab

    Alexandria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) double blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Anaesthesia and Surgical ICU department

Study Record Dates

First Submitted

September 14, 2022

First Posted

September 21, 2022

Study Start

April 20, 2022

Primary Completion

November 30, 2023

Study Completion

June 30, 2024

Last Updated

November 29, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

there is a plan to make individual participant data (IPD) collected in this study, including data dictionaries, available to other researchers

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After study ends upon request
Access Criteria
Accessible through the web site

Locations